Rxsight Inc
NASDAQ:RXST

Watchlist Manager
Rxsight Inc Logo
Rxsight Inc
NASDAQ:RXST
Watchlist
Price: 14.95 USD 1.53% Market Closed
Market Cap: 605.3m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

RXST Price Targets Summary
Rxsight Inc

Wall Street analysts forecast RXST stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RXST is 25.6 USD with a low forecast of 16.16 USD and a high forecast of 44.1 USD.

RXST Lowest Forecast
Wall Street Target
16.16 USD
8% Upside
RXST Average Forecast
Wall Street Target
25.6 USD
71% Upside
RXST Highest Forecast
Wall Street Target
44.1 USD
195% Upside
Lowest
Price Target
16.16 USD
8% Upside
Average
Price Target
25.6 USD
71% Upside
Highest
Price Target
44.1 USD
195% Upside
Rxsight Inc Competitors:
Price Targets
MED
Medartis Holding AG
28% Upside
O
6929
OrbusNeich Medical Group Holdings Ltd
40% Upside
AMS
Advanced Medical Solutions Group PLC
49% Upside
S
688289
Sansure Biotech Inc
38% Upside
MED
Medartis Holding AG
28% Upside
O
6929
OrbusNeich Medical Group Holdings Ltd
40% Upside
AMS
Advanced Medical Solutions Group PLC
49% Upside
S
688289
Sansure Biotech Inc
38% Upside
300888
Winner Medical Co Ltd
9% Upside
7741
Hoya Corp
37% Upside
4549
Eiken Chemical Co Ltd
1% Upside
CERS
Cerus Corp
202% Upside

Revenue
Forecast

Revenue Estimate
Rxsight Inc

For the last 4 years the compound annual growth rate for Rxsight Inc's revenue is 76%. The projected CAGR for the next 3 years is 22%.

76%
Past Growth
22%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Rxsight Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Rxsight Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-30%
Average Miss
What are analyst estimates?

See Also

Summary
RXST intrinsic value, competitors valuation, and company profile.
DCF Valuation
RXST stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RXST stock valuation using valuation multiples.
Wall Street Estimates
RXST price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RXST stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RXST's stock price target?
Price Target
25.6 USD

According to Wall Street analysts, the average 1-year price target for RXST is 25.6 USD with a low forecast of 16.16 USD and a high forecast of 44.1 USD.

What is Rxsight Inc's Revenue forecast?
Projected CAGR
22%

For the last 4 years the compound annual growth rate for Rxsight Inc's revenue is 76%. The projected CAGR for the next 3 years is 22%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 249,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.